High resolution brain spect imaging in a clinical substance abuse practice

Journal of Psychoactive Drugs

Volumn 42, Issue 2, 2010, Pages 153-160

  Amen, Daniel G ^a  

^a Amen Clinics Inc   (United States)

Author keywords

Brain injuries; Brain system pathology; Imaging; SPECT; Substance abuse

Indexed keywords

ADDICTION; ARTICLE; BRAIN; BRAIN CIRCULATION; BRAIN MAPPING; HUMAN; PATHOLOGY; PHYSIOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; HUMANS; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955947955     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2010.10400688     Document Type: Article

References (26)

1. Amen, D.G. 2002. Healing ADD: The Breakthrough Program That Allows You to See and Heal the 6 Types of ADD. New York: Putnam.
2. Amen, D.G. & Routh, L.C. 2004. Healing Anxiety and Depression. New York: Putnam.
3. Amen, D.G.; Hanks, C. & Prunella, J.R. 2008. Predicting positive and negative treatment responses to stimulants with brain SPECT imaging. Journal of Psychoactive Drugs 40 (2): 131-38.
4. Amen Clinics, Incorporated. 2010. Brain SPECT Abstracts for SPECT [Data files]. Available at http://www.amenclinics.com/brain-science/spect-research/spect-abstracts
5. Bursztajn, H.J. 2002. Personal communication.
6. Bush, G. 2008. Neuroimaging of attention deficit hyperactivity disorder: Can new imaging findings be integrated in clinical practice? Child and Adolescent Psychiatric Clinics of North America 17 (2): 385-404, x. [Review]
7. Camargo, E.E. 2001. Brain SPECT in neurology and psychiatry. Journal of Nuclear Medicine 42 (4): 611-23.
8. Catafau, A.M. 2001. Brain SPECT in clinical practice. I: Perfusion. Journal ofNuclear Medicine 42 (2): 259-71.
9. Flaherty, L.T.; Arroyo, W.; Chatoor, I.; Dryden-Edwards, D.; Ferguson, Y.B.; Ferguson, S.; Kraus, L.; Rothe, E.; Russell, A.; Steingard, R.; Wright, H. & Wellek, H. 2005. Brain imaging and child and adolescent psychiatry with special emphasis on SPECT. APA Committee on Children and Families. Opinion Paper I-II.
10. George, M.S. 1991. Neuroactivation and Neuroimaging with SPECT. New York: Springer-Verlag.
11. Holman, B.L.; Carvalho, P.A.; Mendelson, J.; Teoh, S.K.; Nardin, R.; Hallgring, E.; Hebben, N. & Johnson, K.A. 1991. Brain perfusion is abnormal in cocaine-dependent polydrug users: A study using technetium-99m-HMPAO and SPECT. Journal ofNuclear Medicine 32: 1206-10.
12. Insel, T.R. 2005. Judd Marmor Award Lecture, American Psychiatric Association Annual Meeting, Atlanta. GA.
13. Kabakus, N.; Aydin, M.; Akin, H.; Balci, T.A.; Kurt, A. & Kekilli, E. 2006. Fragile X syndrome and cerebral perfusion abnonnalities: A singlephoton emission computed tomographic study. Journal of Child Neurology 21 (12): 1040-46.
14. Kao, CH.; Wang, SJ. & Yeh, S.H. 1994. Presentation of regional cerebral blood How in amphetamine abusers by 99Tcm-HMPAO brain SPECT. Nuclear Medicine Communication 15: 94-98.
15. Kutik, N.O.; Kili, E.O.; Ibis, E.; Aysev, A.; Genoglu, E.A.; Aras, G.; Soylu, A. & Erbay, G. 2000. Brain SPECT findings in long-tenn inhalant abuse. Nuclear Medicine Communications 21 (8): 769-73.
16. Kuperman, K.; Gaffney, G.R.; Hamdan-Allen, G.; Preston, D.F. & Venkatesh, L. 1990. Neuroimaging in child and adolescent psychiatry. Journal of the American Academy of Child & Adolescent Psychiatry 29: 159-72.
17. Levin, J.M.; Holman, B.L.; Mendelson, J.H.; Teoh, S.K.; Garada, B.; Johnson, K.A. & Springer, S. 1994. Gender differences in cerebral perfusion in cocaine abuse: Technetium-99m-HMPAO SPECT study of drug-abusing women. Journal of Nuclear Medicine 35: 1902-09.
18. Mena, I.; Giombetti, R.J.; Miller, B.L.; Garrett, K.; Villanueva-Meyer, J.; Mody, C. & Goldberg, M.A. 1994. Cerebral blood Howchanges with acute cocaine intoxication: Clinical correlations with SPECT, CT, and MRI. In: H. Sorer & R. Rapaka (Eds.) Imaging Techniques in Medications Development: Preclinical and Clinical Aspects. NIDA Research Monograph 138. Rockville, MD: NIDA.
19. Mendelson, J.H.; Holman, B.L.; Teoh, S.K.; Garada, B.; Schwartz, R.B. & Mello, N.K. 1995. Improved regional cerebral blood How in chronic cocaine polydrug users treated with buprenorphine. Journal of Nuclear Medicine 36: 1211-15.
20. Miller, B.L.; Mena, I.; Giombetti, R.; Villanueva-Meyer, J. & Djenderedjian, A.H. 1992. Neuropsychiatric effects of cocaine: SPECT measurements. Journal of Addictive Disorders 11: 47-58.
21. Ryu, Y.H.; Lee, J.D.; Yoon, PH.; Jeon, P.; Kim, D.I. & Shin, D.W. 1998. Cerebral perfusion impairment in a patient with toluene abuse. Journal of Nuclear Medicine 39 (4): 632-33.
22. Saxena, S.; Brody, A.L.; Maidment, K.M.; Smith, E.C.; Zohrabi, N.; Katz, E.; Baker, S.K. & Baxter, L.R. Jr. 2004. Cerebral glucose metabolism in obsessive-compulsive hoarding. American Journal of Psychiatry 161 (6): 1038-48.
23. Saxena, S.; Brody, A.L.; Schwartz, J.M. & Baxter, L.R. 1998. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. British Journal of Psychiatry Supplement 8 (35): 26-37.
24. Tumeh, S.S.; Nagel, J.S.; English, R.J.; Moore, M. & Holman, B.L. 1990. Cerebral abnormalities in cocaine abusers: Demonstration by SPECT perfusion brain scintigraphy. Radiology 176: 821-24.
25. Vasile, R.G. 1996. Single photon emission computed tomography in psychiatry: Current perspectives. Harvard Review of Psychiatry 4 (1): 27-38.
26. Volkow, N.D.; Fowler, J.S.; Wang, G.J.; Hitzmann, R.; Logan, J.; Schyler, D.J.; Dewey, S.L. & Wolf, A.P. 1993. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169-77.